Best Stocks to Buy in May 2024: TSX Healthcare Sector

Three outperforming stocks with strong fundamentals are the best buys in the healthcare sector in May 2024.

The Canadian and US stock markets have the same mix of industry sectors but differ in equity weights by sector. One glaring difference is healthcare. In the US S&P 500 Index, it is the third-largest sector (12.6%) after information technology (28.9%) and financials (13%).

In the S&P/TSX Composite Index, healthcare (0.3%) is the smallest among the 11 primary sectors, while financials (31.3%) and energy (17.1%) are the heavyweights. The healthcare sector seldom outperforms, although, in 2024, individual components beat the broader market.

This May, best in the lot are Vitalhub (TSX: VHI) and Medical Facilities Corp. (TSX: DR). If you’re after monthly passive income and don’t expect much on price appreciation, high-yield NorthWest Healthcare Properties (TSX:NWH.UN) is the logical choice.

Doctor talking to a patient in the corridor of a hospital.

Source: Getty Images

Digital transformation                

Vitalhub is obscure, but the healthcare stock is flying high. At $6.63 per share, current investors enjoy a 62.5% year-to-date gain. The trailing one-year price return is 142.9%. Had you invested $6,500 a year ago, your money would be worth $15,785.71 today.

The $336 million company provides software dedicated to health and human services providers. Its primary purpose is to improve care delivery by developing an ecosystem of harmonious solutions for these sectors. Given the Q1 2024 financial results, its CEO, Dan Matlow, said VitalHub is well-positioned to continue its growth trajectory.

In the three months ended March 31, 2024, revenue and annual recurring revenue (ARR) increased 21% to $15.3 million and $47.8 million, respectively. Notably, EBITDA rose 56% to $3.1 million, while net income soared 713% year over year to $1.3 million.   

“Our strong financial position supports our ambitious growth plans and our commitment to leading the digital transformation in healthcare,” added Matlow.

Unique business model

Prospective investors can earn two ways from Medical Facilities: capital gains and dividends. At $11.80 per share, the healthcare stock is up 32.4% year to date and pays a decent 2.83% dividend. This $288.8 million market cap company owns or has controlling interests in specialty surgical hospitals in Arkansas, Oklahoma, and South Dakota, as well as an ambulatory surgery centre in California.

The business model is unique in that physicians have direct involvement in operations through established partnerships. Medical Facilities’ competitive advantages are their high-quality surgical facilities, the ever-increasing demand for health care, and the growing but fragmented outpatient services market.

In Q1 2024, facility service revenue and income from operations rose 4.5% and 29.6% year over year respectively to $108.3 million and $17.5 million. Because of the strong cash flows, the company reduced debt by $5 million, and the Board approved an 11.8% dividend hike.

Only REIT in the cure sector

NorthWest Healthcare trades at $5.33 per share (+6% year-to-date) and pays a hefty 7.05% dividend. A $7,000 investment today would transform into a recurring monthly passive income of $41.12. The investment pitch for this healthcare-related real estate stock is simple.

This $1.3 billion real estate investment trust (REIT) is the only REIT in the cure sector. NorthWest Healthcare owns and operates healthcare real estate infrastructure. The medical office buildings, hospitals, and clinics are in North America, Brazil, Europe, and Australasia. Besides stable occupancies, the leases are long-term.

Strong fundamentals

Vitalhub, Medical Facilities, and NorthWest Healthcare Properties boast strong fundamentals. The choice depends on your investment objectives: capital gains, dividend income, or both.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vitalhub. The Motley Fool recommends NorthWest Healthcare Properties Real Estate Investment Trust. The Motley Fool has a disclosure policy.

More on Dividend Stocks

person with spyglass looks at ocean horizon
Dividend Stocks

Dividend Investors: Don’t Overlook Peyto! Its Yield Is a Thing of Beauty

Peyto Exploration & Development (TSX:PEY) is an underrated energy stock with a colossal yield and a dirt-cheap multiple.

Read more »

Piggy bank wrapped in Christmas string lights
Dividend Stocks

The $7,000 TFSA Move Most Canadians Leave Until December

An earlier TFSA contribution can simplify your plan, even when the immediate tax saving is smaller than you expect.

Read more »

diversification is an important part of building a stable portfolio
Dividend Stocks

Diversification 101: How Beginners Can Protect Against Market Shocks

Stocks like TD Bank and Fortis provide an anchor to a well-diversified portfolio for resilient long-term performance.

Read more »

man makes the timeout gesture with his hands
Dividend Stocks

Why Dividend Cuts Happen and How to Spot the Warning Signs

Learn why dividend cuts happen and how to spot warning signs, using BCE and TELUS to examine cash flow, debt,…

Read more »

woman stares at chocolate layer cake
Dividend Stocks

Just Turned 50 With Little Saved? Here’s Where to Start

This investing strategy can reduce risk while still delivering decent yield.

Read more »

Trans Alaska Pipeline with Autumn Colors
Dividend Stocks

1 Top Canadian Dividend Stock Down 17% to Consider Now for Lifelong Income

This company has increased the dividend annually for more than three decades.

Read more »

Senior uses a laptop computer
Dividend Stocks

A 4.9% Dividend Stock I Plan to Hold Long Term: What $5,000 Would Collect

This is a solid utility stock to consider on dips for a long-term portfolio with a focus on growing income.

Read more »

shopper carries paper bags with purchases
Dividend Stocks

Your GIC Pays 3% to 4%: This TSX Stock Pays You Every Month Instead

SmartCentres pays more income than an illustrative GIC, but a modest unit-price decline could erase the first-year advantage.

Read more »